The early developments of preeclampsia drugs

Maged Costantine, Cande V. Ananth

Research output: Contribution to journalEditorial

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)867-870
Number of pages4
JournalExpert Opinion on Investigational Drugs
Volume25
Issue number8
DOIs
StatePublished - Aug 2 2016

Keywords

  • Angiogenic imbalance
  • endothelial dysfunction
  • pravastatin
  • preeclampsia
  • pregnancy
  • statins

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

The early developments of preeclampsia drugs. / Costantine, Maged; Ananth, Cande V.

In: Expert Opinion on Investigational Drugs, Vol. 25, No. 8, 02.08.2016, p. 867-870.

Research output: Contribution to journalEditorial

Costantine, Maged ; Ananth, Cande V. / The early developments of preeclampsia drugs. In: Expert Opinion on Investigational Drugs. 2016 ; Vol. 25, No. 8. pp. 867-870.
@article{a1352c50d3d14cbbb6a3cd84320cf184,
title = "The early developments of preeclampsia drugs",
keywords = "Angiogenic imbalance, endothelial dysfunction, pravastatin, preeclampsia, pregnancy, statins",
author = "Maged Costantine and Ananth, {Cande V.}",
year = "2016",
month = "8",
day = "2",
doi = "10.1080/13543784.2016.1196185",
language = "English (US)",
volume = "25",
pages = "867--870",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "8",

}

TY - JOUR

T1 - The early developments of preeclampsia drugs

AU - Costantine, Maged

AU - Ananth, Cande V.

PY - 2016/8/2

Y1 - 2016/8/2

KW - Angiogenic imbalance

KW - endothelial dysfunction

KW - pravastatin

KW - preeclampsia

KW - pregnancy

KW - statins

UR - http://www.scopus.com/inward/record.url?scp=84976905685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976905685&partnerID=8YFLogxK

U2 - 10.1080/13543784.2016.1196185

DO - 10.1080/13543784.2016.1196185

M3 - Editorial

C2 - 27253272

AN - SCOPUS:84976905685

VL - 25

SP - 867

EP - 870

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 8

ER -